share_log

Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $26 Price Target

Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $26 Price Target

尼德姆重申对Phathom Pharmaceuticals的买入评级,维持26美元的目标价。
Benzinga ·  08/12 04:48

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham分析师Joseph Stringer重申Phathom Pharmaceuticals(NASDAQ:PHAT)买入评级,并维持26美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发